SERCLUTAMAB

Approval Year

Name

Type

Language

SERCLUTAMAB

Official Name

English

IMMUNOGLOBULIN G1(238-CYSTEINE), ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR) (HUMAN-MUS MUSCULUS MONOCLONAL ABT-806 AM1 S238C .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL ABT-806 AM1 S238C .KAPPA.-CHAIN, DIMER

Common Name

English

PR-1594407

Code

English

SERCLUTAMAB [USAN]

Common Name

English

PR1594407

Code

English

Serclutamab [WHO-DD]

Common Name

English

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS EPIDERMAL GROWTH FACTOR RECEPTOR (RECEPTOR TYROSINE-PROTEIN KINASE ERBB-1, EC=2.7.10.1))MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN (1-446) (VH (HOMO SAPIENS IGHV4-30-4*01 (81%) (IGHD)-IGHJ4*01 (93%)) (9.7.9) (1-11

Common Name

English

serclutamab [INN]

Common Name

English

Code System Code Type Description

FDA UNII

RY62FD82YX